AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $63K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$63K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 3 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $1.61
- 52-wk high
- $4.46
- High
- $1.66
- 52-wk low
- $1.04
- Low
- $1.58
- Prev close
- $1.62
- Mkt cap
- $559.7M
- Volume
- 8.13M
- Beta
- 0.48
- P/S
- 120.6x
- P/B
- 1.3x
- Profit margin
- +0.0%
- Op margin
- -1011.0%
- ROE
- -42.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ALLO filings
Are insiders buying or selling Allogene Therapeutics Inc (ALLO) stock?
Net selling: insiders sold $63K and bought $0 of ALLO stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. The largest was Douglas, Earl Martin (SVP, General Counsel), who sold $63K. The latest filing was on Aug 25, 2026.
Which members of Congress have traded ALLO recently?
None. No member of Congress disclosed a ALLO trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ALLO smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
What insiders are doing
How top traders are positioned
No tracked top-trader positions in ALLO right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 18.8% above what analysts expected.
Earnings per share
-$0.16 expected
Reports Nov 5, 2026, in 35 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $560M
Valuation
- P/S120.62
- P/B1.33
Quality
- Operating margin-1011.0%
- ROE-42.4%
- ROA-22.1%
Growth
- Beta0.48
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace